PDS Biotechnology (PDSB) Cash & Equivalents (2014 - 2026)
PDS Biotechnology's Cash & Equivalents came in at $5.6 million for Q2 2026, down 82.4% from $31.9 million a year earlier.
Powered by 
Analysis
PDS Biotechnology (PDSB) Cash & Equivalents (2014 - 2026) Analysis & Trends
At the end of FY2025, PDS Biotechnology's Cash & Equivalents was $26.71 million, down 35.9% from FY2024.
- Cash & Equivalents has declined in each of the last three years, with a five-year compound annual growth rate of -1.5% (FY2020 to FY2025).
- Going back by year, Cash & Equivalents was $41.69 million in FY2024 (-26.3%), $56.56 million in FY2023 (-23.4%), $73.82 million in FY2022 (+13.1%) and $65.24 million in FY2021 (+126.2%).
- The Q2 2026 figure represents the lowest quarterly Cash & Equivalents since Q4 2018.
- The fastest year-over-year change in Cash & Equivalents over five years came in Q1 2022 (growth of 135.2%), and the weakest in Q2 2026 (a decline of 82.4%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 976.00 Mn |
| 10 | PDS Biotechnology | 41.94 Mn | 41.94 Mn | - | 5.60 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.60 Mn |
| Dec 31, 2025 | 26.71 Mn |
| Sep 30, 2025 | 26.20 Mn |
| Jun 30, 2025 | 31.90 Mn |
| Mar 31, 2025 | 40.00 Mn |
| Dec 31, 2024 | 41.69 Mn |
| Sep 30, 2024 | 49.80 Mn |
| Jun 30, 2024 | 57.73 Mn |
| Mar 31, 2024 | 66.63 Mn |
| Dec 31, 2023 | 56.56 Mn |
| Sep 30, 2023 | 54.30 Mn |
| Jun 30, 2023 | 60.62 Mn |
| Mar 31, 2023 | 65.20 Mn |
| Dec 31, 2022 | 73.82 Mn |
| Sep 30, 2022 | 71.64 Mn |
| Jun 30, 2022 | 53.00 Mn |
| Mar 31, 2022 | 58.90 Mn |
| Dec 31, 2021 | 65.24 Mn |
| Sep 30, 2021 | 69.74 Mn |
| Jun 30, 2021 | 74.75 Mn |
API Access
PDS Biotechnology Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=PDSB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "PDSB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=PDSB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();